ProfileGDS4132 / 210279_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 21% 19% 23% 26% 22% 18% 22% 17% 24% 26% 34% 32% 27% 24% 49% 54% 43% 27% 29% 29% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10148.613421
GSM201543Muscle PCOS pioglitazone 12134.166919
GSM201544Muscle PCOS pioglitazone 16154.184323
GSM201545Muscle PCOS pioglitazone 20168.879526
GSM201829Muscle PCOS pioglitazone 23152.119922
GSM201830Muscle PCOS pioglitazon 25141.280618
GSM201831Muscle PCOS pioglitazone 27145.541322
GSM201832Muscle PCOS pioglitazone 3136.975217
GSM201833Muscle PCOS pioglitazone 4152.435824
GSM201834Muscle PCOS pioglitazone 8159.505326
GSM201835Muscle PCOS after pioglitazone 10271.341634
GSM201836Muscle PCOS after pioglitazone 12268.587732
GSM201837Muscle PCOS after pioglitazone 16252.330427
GSM201838Muscle PCOS after pioglitazone 20250.108624
GSM201839Muscle PCOS after pioglitazone 232124.649
GSM201840Muscle PCOS after pioglitazone 252142.90354
GSM201841Muscle PCOS after pioglitazone 27297.881343
GSM201842Muscle PCOS after pioglitazone 3249.849827
GSM201843Muscle PCOS after pioglitazone 4268.777329
GSM201844Muscle PCOS after pioglitazone 8264.902629